P2Y12 inhibition should be started at the time of NSTEMI diagnosis -Discussion

1 September 2019 (14:56 - 15:05)
Organised by:
Congress Presentation Part of: Controversies in anti-platelet therapy Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by